Strand Therapeutics Patient with Stage 4 Melanoma Shows Complete Cancer Clearance After Treatment

What was said

"The picture that we have is quite striking. It's basically a body riddled with cancers. They're everywhere. I like to say you don't have to be an oncologist to look at that scan and understand the extent of which this patient responded, sort of just riddled and then no more. We're a year and a half in and they still have no detectable lesions."

Becraft revealed striking clinical results showing a stage 4 melanoma patient with widespread visceral metastases who had exhausted all standard treatments achieved complete cancer clearance with Strand's genetic medicine therapy. The patient, who had failed multiple immunotherapy drugs including Keytruda, remains cancer-free 18 months later. The treatment represents the first demonstration of significant abscopal response in deep organ metastases across multiple patients, not just surface tumors.